Trial Information

Summary: Hypertension Study CVAH631BUS08

Novartis clinical trials is performing this clinical research study to determine the efficacy and safety of the combination of the study drug valsartan plus hydrochlorothiazide (known as Diovan HCT®) compared to patients initiated with either valsartan or hydrochlorothiazide. Participants must be at least 75 years old and have high blood pressure and will be asked to visit the study center 8 to 10 times over a 16 week period. Diovan HCT® has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of high blood pressure.

Participants will be required to visit the study center 8 to 10 times over a 16 week period.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 19, 2008 at 2:55:48 PM